MHRA Case Study Illustrates How MHRA & OxSonics Help Cancer Drugs Go The Extra Mile

London, UK – 15 January 2015 – The Medicines and Healthcare products Regulatory Agency (“MHRA”) has helped OxSonics take a big step towards developing a revolutionary generation of ultrasound devices which aim to enhance delivery of anti-cancer drugs deep into solid tumours. OxSonics Limited (“OxSonics”) was established in July 2013 to develop and commercialise a […]